Darnitsa Boosts Non-Consolidated EBITDA 73% yoy in 2007, Sales by 4%
24 April 2008
Darnitsa, held by Nord Star Pharmashare (4SI 1GR: BUY) posted 4.4% yoy non-consolidated revenue growth in 2007 to USD 73.5 mln. EBITDA grew by 73.1% to USD 14.0 mln (19.1% margin); net income increased by 15.5% to USD 4.1 mln.
